Literature DB >> 6229269

The significance of fibrinogen derivatives in plasma in human renal failure.

D A Lane, H Ireland, I Knight, S Wolff, P Kyle, J R Curtis.   

Abstract

The concentrations in plasma of fibrinogen derivatives fibrinopeptide A (FPA), beta 15-42 antigen and fragment E (FgE) antigen have been determined in patients with renal failure and compared to the concentrations of the platelet release products, beta-thromboglobulin (beta TG) and platelet factor 4 (PF4). In 'partial renal failure' (51Cr-EDTA clearance rate 4-60 ml/min) FPA, beta 15-42 antigen, FgE antigen and beta TG levels were significantly raised above a normal laboratory control group. These levels were further raised in a group of patients whose disease required regular maintenance haemodialysis (51Cr-EDTA clearance rate less than 4 ml/min). PF4 levels were not significantly raised in either group. A statistical analysis of all patient results revealed that FPA, beta 15-42 antigen and FgE antigen levels all correlated with beta TG levels but not with PF4 levels. It is known that beta TG is catabolized by the kidney but PF4 is not and that elevated beta TG levels in renal failure are caused by impaired elimination rather than increased production. These results suggest that the plasma levels of these three fibrinogen derivatives are elevated in renal disease at least in part by decreased elimination rather than by increased thrombin and plasmin activities alone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6229269     DOI: 10.1111/j.1365-2141.1984.tb03953.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Clot Structure: A Potent Mortality Risk Factor in Patients on Hemodialysis.

Authors:  Katharina Schuett; Anna Savvaidis; Sebastian Maxeiner; Katharina Lysaja; Vera Jankowski; Stephan H Schirmer; Nada Dimkovic; Peter Boor; Nadine Kaesler; Friedo W Dekker; Jürgen Floege; Nikolaus Marx; Georg Schlieper
Journal:  J Am Soc Nephrol       Date:  2017-01-05       Impact factor: 10.121

2.  Fibrinogen Manchester. Detection of a heterozygous phenotype in the intraplatelet pool.

Authors:  C Southan; D A Lane; I Knight; H Ireland; J Bottomley
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

3.  Fibrinogen--proteolysis in acute myelogenous leukemia (AML).

Authors:  T Eckhardt; M Koch
Journal:  Blut       Date:  1986-07

4.  Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.

Authors:  Salim S Hayek; Yi-An Ko; Mosaab Awad; Hina Ahmed; Brandon Gray; Kareem Mohammed Hosny; Hiroshi Aida; Melissa J Tracy; Changli Wei; Sanja Sever; Jochen Reiser; Arshed A Quyyumi
Journal:  Kidney Int Rep       Date:  2017-02-09

5.  Blood coagulation system in patients with chronic kidney disease: a prospective observational study.

Authors:  Meng-Jie Huang; Ri-Bao Wei; Yang Wang; Ting-Yu Su; Ping Di; Qing-Ping Li; Xi Yang; Ping Li; Xiang-Mei Chen
Journal:  BMJ Open       Date:  2017-06-01       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.